BTMD
biote Corp.
Key Financials
Net Income
$27.0M
↑ 756.7%
Operating Income
$35.6M
↑ 12.5%
Revenue
$192.2M
↓ 2.5%
Total Assets
$107.6M
↓ 12.1%
EPS (Diluted)
$0.74
↑ 722.2%
Shareholders' Equity
$-58539000.00
↑ 44.7%
Cash & Equivalents
$24.1M
↓ 38.7%
Total Liabilities
$158.0M
↓ 29.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/12/2026 | View on SEC |
| 10-Q | 8/7/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| SCHEDULE 13G/A | 7/27/2026 | View on SEC |
| 8-K/A | 6/17/2026 | View on SEC |
| 4 | 6/16/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 4 | 6/10/2026 | View on SEC |
| 8-K | 6/2/2026 | View on SEC |
| 8-K | 5/18/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BTMD |
| Company Name | biote Corp. |
| CIK | 1819253 |
| Sector | Medicinal Chemicals & Botanical Products |
| Industry | Accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2833 |
| SIC Description | Medicinal Chemicals & Botanical Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 972-486-9346 |